The 12th Invest in ME Conference, Part 1
OverTheHills presents the first article in a series of three about the recent 12th Invest In ME international Conference (IIMEC12) in London.
Discuss the article on the Forums.

Phase 3 Norwegian trials

Discussion in 'Rituximab: News and Research' started by neweimear, Jun 12, 2017.

  1. neweimear

    neweimear Senior Member

    Messages:
    212
    Likes:
    603
    Does anyone have any idea how long it will be from October 2018 when the phase 3 Norwegian trials conclude until the results are published?
     
    neweimear, Jun 12, 2017
    #1
  2. Jo Best

    Jo Best Senior Member

    Messages:
    1,032
    Likes:
    6,231
    Do you mean October 2017 when the results will be unblinded?
     
    Jo Best, Jun 12, 2017
    #2
  3. BurnA

    BurnA Senior Member

    Messages:
    2,086
    Likes:
    9,872
    Personal guess would be 3-6 months.
    But it's a guess.
     
    BurnA, Jun 12, 2017
    #3
    Valentijn, L'engle, AndyPR and 1 other person like this.
  4. neweimear

    neweimear Senior Member

    Messages:
    212
    Likes:
    603
    Yes I meant October 2017....sorry!
     
    neweimear, Jun 12, 2017
    #4
  5. TrixieStix

    TrixieStix Senior Member

    Messages:
    539
    Likes:
    891
    I think I remember someone saying they figured it would be about June (2018) or so
     
    TrixieStix, Jun 13, 2017
    #5
  6. Londinium

    Londinium Senior Member

    Messages:
    178
    Likes:
    1,420
    That seems reasonable. 3-6 months for peer review, going by the 'date accepted' vs. 'date published' on similar papers. If unblinding is in October, add a few months for the data to be analysed and the paper to be drafted, so June next year seems about right. Hopefully we'd get some hints before then (e.g. if we see all systems go on the UK trial, that might suggest promising unpublished results).
     
    Londinium, Jun 13, 2017
    #6
    Jo Best, TrixieStix and BurnA like this.

See more popular forum discussions.

Share This Page